The invention relates to a 2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl-sulfonamide derivative being (A) a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; or (B) a compound selected from a certain group of 2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl-sulfonamide derivatives disclosed in the specification; in free form or in salt form; to their preparation, to their use as medicament and to medicaments comprising them. In a first aspect, the invention provides prodrugs of AMPA receptor antagonists which potentially useful in the treatment of a wide range of disorders, particularly epilepsy.
该发明涉及一种2,4-二氧代-1,4-二氢-2H-
喹唑啉-3-基-磺酰胺衍
生物(A),其为化合物(I)的一种,其中取代基如规范中所定义;以自由形式或盐形式存在;或者(B)所述规范中披露的一组2,4-二氧代-1,4-二氢-2H-
喹唑啉-3-基-磺酰胺衍
生物中选择的一种化合物,以自由形式或盐形式存在;以及它们的制备,用作药物以及包含它们的药物。在第一个方面,该发明提供
AMPA受体拮抗剂的前药,可能在治疗各种疾病,特别是癫痫症方面有用。